A New Chapter
BioAdaptives® is proud to announce the appointment of James Keener as our new Chief Executive Officer and Chairman of the Board. With nearly three decades of leadership and operational experience, James brings a wealth of expertise to our team.
James Keener’s proven ability to drive growth and his strategic vision instill great optimism for the future of BioAdaptives®. Under his leadership, BioAdaptives® is set to drive market expansion and enhance our product offerings. We are not just creating products; we are shaping the future of health and wellness.
James Keener
Chairman & CEO
BioAdaptives® new Chairman and CEO, brings 30 years of multisector experience and is known for transforming underperforming ventures. He aims to drive growth and innovation in advanced nutrition and wellness solutions.
Gimhana Dissanayake
Director
Gimhana Dissanayake joins BioAdaptives®, Inc. as a Board Director, leveraging his extensive experience in operational sales and strategic partnerships from The Hertz Corporation to drive growth and innovation in the health and wellness sector.
Mark Frissora
Director
Mark P. Frissora, most recently the CEO and President of Caesars Entertainment, has 42 years of business experience across managerial and functional roles. He joined Caesars in 2015 and previously served as Chairman and CEO of Hertz Global Holdings and Tenneco, Inc., leading both Fortune 500 companies through transformative growth. Frissora has a 20-year track record of creating stakeholder value at highly leveraged companies in private equity and public markets, meeting or exceeding expectations in over 92% of 65 quarters during two significant recessions. He led two companies through successful IPOs and guided Caesars out of bankruptcy to its NASDAQ relisting in 2017. At Tenneco, where he served as Chairman and CEO from 1999 to 2006, shareholder value tripled, revenue rose 39%, and the company earned top industry awards for shareholder returns. During his tenure at Hertz from 2006 to 2014, shareholders saw a 3.6x return post-IPO, with a special dividend paid after the launch. At Caesars, he drove initiatives that increased EBITDA by $812M (55%) and margins by 930 bps, creating $12.5B in value during its bankruptcy turnaround. Frissora currently chairs Arencibia, an advanced engineering company, and co-founded Goodwrx, a gig economy technology solution. He previously served on the boards of Caesars Entertainment, Aptiv, Walgreens Boots Alliance, FMC Corporation, and NCR Corporation, holding key leadership roles on governance, compensation, and finance committees. Mark holds a B.A. from The Ohio State University and has completed executive programs at Babson College and Thunderbird School of Global Management.
BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all of the shares they own on the Record Date.
